Browse Studies — Arctuva

Phase 2

Mitigating Diabetic Ketoacidosis in People With T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation Into an Enhanced Glucose Ketone Report

The goal of this clinical trial is to develop and evaluate a novel diabetes ketoacidosis risk mitigation strategy to support the safe use of sodium-glucose cot…

Type 1 Diabetes MellitusChronic Kidney Disease (CKD) With Diabetes Mellitus (DM)Chronic Kidney Disease+2 more

Estimated

~$10 – $7,500

HealthPartners InstituteNCT07325201

Observational

Effects of Acute and Chronic Ketone Ester Consumption on Exercise Tolerance and Cardiac Function in Subjects With Diabetes

This study is being done to evaluate how a ketone ester (KE) supplement affects heart function and health in people with diabetes compared to a placebo supplem…

Type 2 DiabetesKetone Body MetabolismKetones, Metabolism

Estimated

~$10 – $6,250

Ohio State UniversityNCT06078683

Phase 2

Evaluation of a Novel Insulin Sensitizer on Glycemic Control, Insulin Usage, and Cardiovascular Biomarkers in People With Type 1 Diabetes Who Use Closed-loop Automated Insulin Delivery

The purpose of this study is to see if the study drug CIR-0602K will improve glucose time-in-range and/or lower total daily insulin dose in people with type 1 …

Type 1 Diabetes (T1D)Glycemic Control for Diabetes MellitusInsulin+2 more

Estimated

~$10 – $6,250

University of VirginiaNCT07186660